Family genetic testing could prevent ovarian cancer

NCT ID NCT04009148

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at whether offering genetic testing to family members of people with hereditary breast and ovarian cancer syndrome helps more relatives learn about their own cancer risk. Researchers will follow 118 participants and their relatives to see how many choose to get tested. The goal is to understand how well cascade testing works in real families.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
CASCADE genetic screening (family-based genetic testing)
What this could lead to
If successful, this could show that cascade testing helps more family members learn their cancer risk and take preventive steps.
What could go wrong
This is an observational study, not a treatment trial. It may not prove that cascade testing changes health outcomes, and results may not apply to all families.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BRCA-MUTATED OVARIAN CARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • NYU Langone Health

    New York, New York, 10016, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.